SCOPE Summit 2026 | Meet Image Analysis Group (IAG) |📅 Feb 2–5 |📍Booth #1526
SCOPE Summit 2026: Meet Image Analysis Group (IAG)đź“Ť Imaging CRO at Booth #1526
Meet Image Analysis Group (IAG) at SCOPE Summit 2026 in Orlando to discuss centralized imaging, AI‑enabled endpoints and radiomics for global clinical trials.​ 📅 February 2–5, 2026 | 📍 Rosen Shingle Creek, Orlando, FL | 📍 Booth 1526
Book a Meeting with our Executive Team at SCOPE
If you are planning a clinical trial that will use imaging to assess safety and efficacy of a new drug candidate, schedule time with our experts at the booth.
Image Analysis Group is proud to be attending SCOPE Summit 2026 in Orlando, joining industry leaders to shape the future of clinical trial operations and innovation. As a global imaging CRO, IAG will be meeting sponsors to discuss centralized imaging, AI-enabled workflows, and robust, regulator-ready endpoints that make trials faster, smarter, and more patient-focused.
Why Visit IAG at SCOPE?
- Reduce operational risk and variability in clinical trials with centralized imaging workflows.
- Ensure high‑quality, regulatory‑ready imaging data across Phase I–IV studies.
- Reduce your site burden by incorporating DYNAMIKA as a central imaging data management platform
- Leverage AI without compromising scientific rigor or compliance.
What Does Image Analysis Group Do for Imaging in Clinical Trials?
Imaging Strategy & Endpoint Selection
We support sponsors and CROs in defining, validating, and operationalizing imaging endpoints aligned to protocol objectives and regulatory expectations.
Central Reading & Image Management
End‑to‑end global image management and independent central review, ensuring consistency, quality and traceability across sites and regions for imaging‑driven studies.
AI-Enabled & Digital Imaging Solutions
Integration of AI, radiomics and digital measures where appropriate, enhancing efficiency, insight and scalability while maintaining medical and scientific oversight.
Scalable Delivery Across Clinical Development
From early‑phase to late‑phase and post‑marketing trials, we support imaging operations across complex, multi‑site global programs.
Who Does Image Analysis Group (IAG) Support?
- Clinical Operations & Trial Delivery Leaders
Managing imaging logistics, vendors, timelines and operational risk across global studies. - Chief Medical Officers & Medical Directors
Overseeing clinical strategy, endpoint selection, and evidence generation. - Therapeutic Area & Scientific Leadership
Ensuring imaging endpoints are scientifically sound, reproducible, and clinically meaningful. - Biotech, Pharma & CRO Clinical Teams
Delivering imaging‑driven trials efficiently while maintaining quality, compliance and scalability.
For more information about IAG’s work or to schedule time at SCOPE 2026, contact contact@ia-grp.com.
How Does IAG Partner with Sponsors?
We work as an extension of your clinical operations team, collaborating closely with medical, operational, and scientific stakeholders through:
- Flexible engagement models aligned with trial needs and timelines.
- Hands-on collaboration from protocol design through to delivery
- Clear communication, transparency, and accountability across imaging vendors and sites.
- Dedicated focus on de-risking imaging trials, simplifying complexity and supporting regulatory submissions.
SCOPE Summit 2026: Questions and Answers
How can I book a meeting with Image Analysis Group at SCOPE Summit 2026?
How can I book a meeting with Image Analysis Group at SCOPE Summit 2026?
You can book a meeting with Image Analysis Group at SCOPE Summit 2026 by using the “Book a meeting” button on this page or emailing contact@ia-grp.com with your preferred date and time during the conference in Orlando, FL.
The IAG team will confirm a slot around key SCOPE sessions so you can discuss your upcoming or ongoing clinical trials in person.
What topics can I discuss with IAG at SCOPE Summit 2026?
What topics can I discuss with IAG at SCOPE Summit 2026?
At SCOPE Summit 2026, you can discuss centralized imaging, AI‑enabled endpoints, radiomics and imaging strategy for global clinical trials with the Image Analysis Group team.
​
Sponsors also use SCOPE meetings to explore how IAG’s DYNAMIKA™ platform can streamline image management, central reads and interim analyses across multi‑site studies.
How does DYNAMIKA™ support imaging in SCOPE‑relevant clinical trials?
How does DYNAMIKA™ support imaging in SCOPE‑relevant clinical trials?
DYNAMIKA™ is IAG’s proprietary imaging platform that supports SCOPE‑relevant clinical trials by standardizing image collection, anonymization, quality control and central review across global sites.
​
It provides real‑time visibility on imaging data, reduces query and rescan rates and helps sponsors reach database lock and regulatory‑ready submissions faster.
Why should SCOPE attendees choose IAG as their imaging CRO?
Why should SCOPE attendees choose IAG as their imaging CRO?
SCOPE attendees choose Image Analysis Group as their imaging CRO because IAG combines nearly 20 years of imaging expertise with its integrated platform, DYNAMIKA™, to de‑risk clinical development.
​
The team designs and executes imaging strategies and endpoints across oncology, neuro‑oncology, immunology and rare disease trials, supporting more than 700 studies globally.
Which clinical trial teams should meet IAG at SCOPE Summit 2026?
Which clinical trial teams should meet IAG at SCOPE Summit 2026?
Clinical operations leaders, trial delivery teams, CMOs, medical directors and scientific leads planning imaging‑driven trials will benefit most from meeting IAG at SCOPE Summit 2026.
​
These stakeholders can review pipeline studies with IAG experts, pressure‑test imaging endpoints and explore how DYNAMIKA™ can improve timelines, data quality and operational scalability.
How can SCOPE Summit 2026 attendees learn more about IAG and the DYNAMIKA platform after the conference?
How can SCOPE Summit 2026 attendees learn more about IAG and the DYNAMIKA platform after the conference?
SCOPE Summit 2026 attendees can learn more about Image Analysis Group and the DYNAMIKA™ platform by following our LinkedIn page, where we will shortly announce an in‑depth webinar on centralized imaging, AI‑enabled endpoints and radiomics in clinical trials. Please watch for the webinar registration link and updates on our LinkedIn feed in the coming days.
Follow the official IMAGE ANALYSIS GROUP page here: https://www.linkedin.com/company/image-analysis-ltd
About Image Analysis Group (IAG)
Image Analysis Group (IAG) is a trusted partner to life sciences companies, combining deep expertise in medical imaging with the innovative power of its proprietary platform, DYNAMIKA™, to de-risk clinical development and accelerate the delivery of lifesaving therapies to patients. The IAG team designs and executes the imaging part of clinical trials that rely on radiological endpoints to demonstrate the safety and efficacy of new drug candidates. By using AI-powered endpoints and automating data management processes, with IAG you accelerate start-up and database lock, gain real-time visibility on trial progress, ensure clean data for regulatory submissions, and maximize patient recruitment speed.
For nearly 20 years, IAG has supported more than 700 clinical trials globally, helping biotech and pharmaceutical sponsors make confident, data‑driven decisions on their development portfolios.
